• Return to Headlines

Chemocentryx Inc is Among the Companies in the Biotechnology Industry With the Highest Price to Cash Flow (CCXI, RGEN, GHDX, RTRX, OSIR)

By Nick Russo

Below are the three companies in the Biotechnology industry with the highest price to cash flow ratios. Often companies with the lowest ratio present the greatest value to investors.

Chemocentryx Inc ranks highest with a a price to cash flow ratio of 524.21. Repligen Corp is next with a a price to cash flow ratio of 315.35. Genomic Health I ranks third highest with a a price to cash flow ratio of 126.37.

Retrophin Inc follows with a a price to cash flow ratio of 98.41, and Osiris Therapeut rounds out the top five with a a price to cash flow ratio of 92.84.

SmarTrend recommended that subscribers consider buying shares of Osiris Therapeut on December 31st, 2018 as our technology indicated a new Uptrend was in progress when shares hit $13.43. Since that recommendation, shares of Osiris Therapeut have risen 41.5%. We continue to monitor Osiris Therapeut for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest price to cash flow chemocentryx inc repligen corp genomic health i retrophin inc :osir osiris therapeut

Ticker(s): CCXI RGEN GHDX RTRX